Local Public Health Alert: COVID-19 infection rates remain high in Mesa County.  Click here to learn more.

Español English

Main Phone Line
(970) 248-6900

Public Health Emerging Issues

March 18, 2021

 

COVID-19 VACCINATION UPDATE 

 

  • As of the week ending March 12, 31,435 first doses and 14,820 second doses have been administered in Mesa County for a total of 46,255 doses. A Vaccine Dashboard is updated weekly on the Mesa County Public Health (MCPH) website. 
  • On Wednesday, March 17, Mesa County’s mass vaccination site at the Grand Junction Convention Center became one of six state-run mass vaccination sites.
  • The new partnership with the state allows any person in Colorado to get vaccinated at the convention center. 
  • MCPH is increasing available appointment slots for vaccine at the convention center and has opened eligibility.
    • Visit our website for scheduling links available in English and Spanish
    • If your phase or reason for qualification says ‘open for scheduling,’ you will be directed to our self-scheduling tool to make your vaccine appointment.
    • Appointments may be available as soon as the next day, increasing access to the vaccine and getting us closer to community vaccination goals, allowing our community to reopen more quickly.
  • With expanded eligibility we continue to prioritize those who are most at risk due to age or working conditions including:
    • People ages 50 and older
    • Student-facing higher education faculty and staff
    • Frontline essential workers in food/restaurant services
    • Frontline essential workers in manufacturing
    • Frontline essential workers for the U.S. Postal Service
    • Frontline essential workers in public transit
    • Frontline essential workers in public health
    • Frontline essential human service workers
    • Faith leaders
    • Frontline essential direct care providers for people experiencing homelessness
    • Frontline essential journalists
    • Continuity of local government
    • Continuation of operations for state government
    • Adults who received a placebo during COVID-19 vaccine trials
    • People age 16-49 with one high-risk condition